Regulatory compliant product development for novel and biosimilar products.
We shall develop and deliver a ready Process with Optimal expression to sustain in the market of competition.
We offer product design and development to our clients to build portfolio in Cell and Gene therapy.
Mammalian and Microbial biosimilar product development services using platform technology for high titer and recovery. Services includes design to Market approval.
Qualified team of professional provides a wide range of cloning services for bacterial and mammalian nature with complete regulatory compliant data packages.
Developing analytical methods based on orthogonal approach for Novel and Biosimilar product with a precise data package and effective onsite training and method transfer.
Theertha team is of very enthusiastic, like-minded who are committed to achieve and secure a strategic position in the global market by combining the development of innovative platform, novel and biosimilar products that are in high demand.